👹Emo😈 🔜MFF
LightNews LightNews
banner
emokiddio.bsky.social
👹Emo😈 🔜MFF
@emokiddio.bsky.social
25 followers 250 following 5 posts
★ Heyo I’m Emo ┇ Genderfluid ⟦they/he/she⟧ ┇ 28 ┇ Latinx/e-Mexican🇲🇽 ┇ ENG/ESP ┇ I make Artwork & Music★
Posts Replies Media Videos
emokiddio.bsky.social
I’m glad to hear that you got to spend time and feel fulfilled in your goodbye to him. I hope your mom will also get to take time to appreciate this time now and that you are there for her
November 21, 2025 at 2:08 AM
emokiddio.bsky.social
Soooo happy for you. I know there’s more to go, but I’m sure this is such a huge relief and this will help to actually allow yourself to rest when you need it. You are so deserving of it
November 20, 2025 at 4:36 PM
emokiddio.bsky.social
I’m charging interest. $5 per post.
November 12, 2025 at 7:54 PM
Reposted by 👹Emo😈 🔜MFF
solardog.bsky.social
solonsite.com Making a note, my dad chipped in and made cutting boards with the direct intention to help bring down my debt for folks who wanted one.
November 12, 2025 at 2:21 AM
emokiddio.bsky.social
You’re an amazing & inspiring person. I chatted with you briefly MFF, about your booth and adore wearing the Defy the Odds tee I got from you. No person deserves to struggle with this debt & I will definitely try my best to support & share widely. Wishing the absolute best of luck & peace to you!
November 12, 2025 at 2:51 AM
Reposted by 👹Emo😈 🔜MFF
sailorrooscout.bsky.social
According to the study’s authors, COVID vaccination was effective in all ALL groups and in persons with OR without major chronic conditions.

The study has been published in the New England Journal of Medicine. YES, it is PEER-REVIEWED.
• www.nejm.org/doi/full/10....

🧪🧵⬇️
Abstract BACKGROUND Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, contemporary evidence on vaccine effectiveness against clinically relevant outcomes is needed. METHODS We conducted an observational study that used the electronic health records of the Department of Veterans Affairs to evaluate the effectiveness of the 2024-2025 Covid-19 vaccine among veterans who received the Covid-19 and influenza vaccines on the same day (164,132 participants) and in an active-comparator group of veterans who received the influenza vaccine only (131,839 participants), between September 3 and December 31, 2024. Participants were followed for 180 days or until the occurrence of an outcome, whichever came first. We used inverse-probability-weighted models to estimate vaccine effectiveness (calculated as 1 minus the risk ratio) against Covid-19-associated emergency department visits, hospitalizations, and deaths at 6 months. RESULTS At 6 months of follow-up, the estimated vaccine effectiveness was 29.3% (95% confidence interval [CI], 19.1 to 39.2) against Covid-19-associated emergency department visits (risk difference per 10,000 persons, 18.3; 95% CI, 10.8 to 27.6), 39.2% (95% Cl, 21.6 to 54.5) against Covid-19-associated hospitalizations (risk difference per 10,000 persons, 7.5; 95% Cl, 3.4 to 13.0), and 64.0% (95% CI, 23.0 to 85.8) against Covid-19-associated deaths (risk difference per 10,000 persons, 2.2; 95% Cl, 0.5 to 6.9). Vaccine effectiveness against a composite of these outcomes was 28.3% (95% CI, 18.2 to 38.2), with a risk difference per 10,000 persons of 18.2 (95% Cl, 10.7 to 27.5). The Covid-19 vaccine was associated with decreased risks of these outcomes across prespecified subgroups defined according to age (<65 years, 65 to 75 years, and >75 years), the presence or absence of major coexisting conditions, and immunocompetence status. CONCLUSIONS In this national cohort of U.S. veterans, the receipt of the 2024-2025 Covid-19 vaccine was associated with decreased risks of severe clinical outcomes. (Funded by the Department of Veterans Affairs.)
November 7, 2025 at 5:02 PM